Department of Family Medicine/Supportive Care Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea.
Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Sci Rep. 2023 Jan 5;13(1):183. doi: 10.1038/s41598-022-26964-8.
Common etiologies between age-related macular degeneration (AMD) and kidney disease advocate a close link between AMD and end-stage renal disease (ESRD). However, the risk of ESRD in people with AMD was not reported. Here, we investigated the association between AMD and the risk of ESRD by using a nationwide, population-based cohort data in Korea. 4,206,862 participants aged 50 years or older were categorized by presence of AMD and visual disability. Risk of ESRD was the primary outcome. Cox regression hazard model was used to examine the hazard ratios (HRs) with adjustment for potential confounders. Stratified analyses by age, sex, baseline kidney function, and cardiometabolic comorbidities were performed. During the mean 9.95 years of follow-up, there were 21,759 incident ESRD events (0.52%). AMD was associated with 33% increased risk of ESRD (adjusted HR [aHR] 1.33, 95% confidence interval [CI] 1.24-1.44), and the risk was even higher when accompanied by visual disability (aHR 2.05, 95% CI 1.68-2.50) than when not (aHR 1.26, 95% CI 1.17-1.37). Age, baseline kidney function, and cardiometabolic comorbidities significantly interact between AMD and the risk of ESRD. Our findings have clinical implications on disease prevention and risk factor management of ESRD in patients with AMD.
年龄相关性黄斑变性(AMD)和肾脏疾病的常见病因表明 AMD 与终末期肾病(ESRD)之间存在密切联系。然而,AMD 患者发生 ESRD 的风险尚未报道。在这里,我们使用韩国全国性的基于人群的队列数据,研究 AMD 与 ESRD 风险之间的关系。纳入了 4206862 名年龄在 50 岁或以上且患有 AMD 和视力障碍的患者。ESRD 是主要的观察结局。使用 Cox 回归风险模型,调整潜在混杂因素后,检验风险比(HRs)。并进行了分层分析,包括年龄、性别、基线肾功能和心血管代谢合并症。在平均 9.95 年的随访期间,有 21759 例 ESRD 事件(0.52%)。AMD 与 ESRD 风险增加 33%相关(调整后的 HR [aHR] 1.33,95%置信区间 [CI] 1.24-1.44),当伴有视力障碍时风险更高(aHR 2.05,95%CI 1.68-2.50),而不伴有视力障碍时风险则较低(aHR 1.26,95%CI 1.17-1.37)。年龄、基线肾功能和心血管代谢合并症在 AMD 与 ESRD 风险之间存在显著交互作用。我们的研究结果对 AMD 患者的疾病预防和 ESRD 风险因素管理具有临床意义。